CTVA Stock Chart & Stats
$1375.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1375.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$998.00 - $1,600.19
Previous CloseN/A
Volume0.00
Average Volume (3M)105.00
Market Cap
$929.00B
Enterprise Value$59.23K
Total Cash (Recent Filing)$2.37B
Total Debt (Recent Filing)$4.88B
Price to Earnings (P/E)52.0
Beta0.28
Next Earnings
Nov 11, 2026EPS Estimate
-6.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.51
Shares Outstanding667,196,000
10 Day Avg. Volume2
30 Day Avg. Volume105
Financial Highlights & Ratios
PEG Ratio1.89
Price to Book (P/B)1.89
Price to Sales (P/S)2.62
P/FCF Ratio16.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,673.59Price Target Upside21.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)66.81
Revenue Forecast (FY)$321.21B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetCorteva’s low leverage and substantial equity base provide financial resilience and flexibility through agricultural cycles. This supports continued investment in research, product development and commercial execution while reducing the balance-sheet strain that can limit strategic options during weaker demand periods.
Raised 2026 GuidanceHigher full-year guidance, backed by first-half sales, EBITDA and margin growth, indicates management sees sufficient operating momentum to offset known seasonal and pricing pressures. The outlook suggests productivity gains, improved mix and commercial execution can support earnings growth over the coming quarters.
Technology And New-Product PipelineA growing contribution from newly launched crop-protection products demonstrates the value of Corteva’s innovation platform and R&D investment. Product introductions can refresh the portfolio, support differentiated demand and partially offset mature-product pricing pressure, reinforcing longer-term competitive positioning.
Bears Say
Sharp TTM Revenue DeclineThe latest trailing-period revenue contraction signals a weakened growth trajectory and raises execution risk even though the company retains substantial scale. Persistent weakness would make it harder to absorb fixed costs, sustain investment intensity and convert the raised earnings outlook into durable growth.
Free Cash Flow VolatilityThe substantial TTM reduction in operating and free cash flow weakens near-term internal funding capacity and makes cash generation less predictable. Although cash conversion remains meaningful, the step-down could constrain capital allocation flexibility if weaker cash performance persists beyond the stated one-time impacts.
Crop-Protection Pricing PressureSustained pricing pressure in crop protection can erode revenue quality and margins, particularly where competitive intensity is elevated. Lower prices require continued volume growth, productivity savings or product innovation merely to preserve earnings, increasing the execution burden across the portfolio.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $998.00 and its highest was $1600.19 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $929.00B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Nov 11, 2026 which is in 44 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Jul 30, 2026. The company reported $40.662 earnings per share for the quarter, beating the consensus estimate of $39.53 by $1.131.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva does not currently pay dividends.
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is -6.82.
How many shares outstanding does Corteva have?
Corteva has 667,196,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of $40.662 in its last earnings report, beating expectations of $39.53. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in MX:CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,673.59 (21.72% Upside)
$1,673.59 (21.72% Upside)
Blogger Sentiment
Bullish
MX:CTVA Sentiment 63%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.15%
12-Months-Change
Fundamentals
Return on Equity
0.81%
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.View all MX:CTVA earnings summariesCTVA Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
CTVA Stock 12 Month Forecast
Average Price Target
$1,673.59
▲(21.72% Upside)